Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 21, 2016; 22(3): 1224-1235
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1224
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1224
Cancer location | PAKs | Alteration | Ref. | |
Gene amplification | Gene or protein overexpression | |||
Oesophagus | PAK4 | √ | [86] | |
Gallbladder | PAK4 | √ | [44] | |
Liver | PAK4 | √ | [64] | |
PAK5 | √ | [21] | ||
PAK6 | √ | [67] | ||
Pancreas | PAK4 | √ | √ | [16,32,45,46] |
Stomach | PAK4 | √ | [48,79] | |
PAK5 | √ | [20] | ||
Colon | PAK4 | √ | [47] | |
PAK5 | √ | [56] | ||
PAK6 | √ | [95] |
- Citation: Shao YG, Ning K, Li F. Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer. World J Gastroenterol 2016; 22(3): 1224-1235
- URL: https://www.wjgnet.com/1007-9327/full/v22/i3/1224.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i3.1224